Takeda Jury Asked to Find Company Liable for Man’s Cancer Death

Takeda Pharmaceutical Co. (4502) should be found liable for causing the bladder-cancer death of a man who took its diabetes control drug Actos, an attorney for his widow and children told a Chicago jury today.

The survivors of William Whitlatch should be awarded at least $10 million for pain, suffering and financial losses arising from his death in 2006, lawyer Steven Maher told jurors. Delivering his closing arguments in a four-week trial, Maher said the drug company failed to disclose risks associated with the medicine.

The case is the first of more than 3,000 filed in Illinois to go to trial, Maher’s co-counsel, Tor Hoerman, said in an interview.

Takeda’s defense attorney Sherry Knutson countered in her summation that the Whitlatch attorneys had failed to prove Takeda’s drug caused the death of a man who’s diabetes and former smoking habit had increased his likelihood of developing cancer.

The case is Whitlatch v. Takeda Pharmaceuticals America Inc., 2012-L-006087, Cook County, Illinois, Circuit Court, Law Division (Chicago).

To contact the reporter on this story: Andrew Harris in federal court in Chicago at aharris16@bloomberg.net

To contact the editor responsible for this story: Michael Hytha at mhytha@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.